Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Court Nixes BMS Block Of Mylan’s Venezuela Atazanavir Exports

This article was originally published in PharmAsia News

Executive Summary

Shortly after Gilead Sciences signed a historic deal with Indian generic companies for supplies of sofosbuvir to over 90 countries, another licensing agreement has reached a flashpoint. Bristol-Myers Squibb and Mylan are in court over rights to export atazanavir to Venezuela, with the first round in favor of Mylan.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts